ScholarIQanswers from OpenAlex & ORCID
George N. Thalmann
ResearcherPublications, citations & collaboration network
George N. Thalmann is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does George N. Thalmann have?
ScholarIQindexed works
George N. Thalmann has 813 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does George N. Thalmann have?
ScholarIQcitation count
George N. Thalmann has 30,221 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of George N. Thalmann?
ScholarIQh-index
George N. Thalmann has an h-index of 87 in OpenAlex.
What is the i10-index of George N. Thalmann?
ScholarIQi10-index
George N. Thalmann has an i10-index of 266 in OpenAlex.
What is the ORCID of George N. Thalmann?
ScholarIQorcid
The ORCID for George N. Thalmann is on the source record.
What is the OpenAlex record for George N. Thalmann?
ScholarIQopenalex
The OpenAlex for George N. Thalmann is on the source record.
What are the most-cited papers on George N. Thalmann?
ScholarIQmost cited works
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines
J. Alfred Witjes, Harman Max Bruins, Richard Cathomas, Éva Compérat, Nigel C. Cowan, Georgios Gakis, Virginia Hernández, Estefania Linares Espinós, Anja Lorch, Y. Neuzillet, Mathieu Rouanne, George N. Thalmann, Erik Veskimäe, María J. Ribal, Antoine G. van der Heijden
Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial
Nicholas D. James, Matthew R. Sydes, Noel W. Clarke, Malcolm D. Mason, David P. Dearnaley, Melissa Spears, A.W.S. Ritchie, Christopher Parker, John M. Russell, Gerhardt Attard, Johann S. de Bono, William Cross, Robert J. Jones, George N. Thalmann, Claire Amos, David Matheson, Robin Millman, Mymoona Alzouebi, S. Beesley, Alison Birtle, Susannah Brock, Richard Cathomas, Prabir Chakraborti, Simon Chowdhury, Audrey Cook, Tony Elliott, Joanna Gale, Stephanie Gibbs, John D. Graham, John Hetherington, Robert Hughes, Robert Laing, Fiona McKinna, Duncan B. McLaren, Joe M. O’Sullivan, Omi Parikh, C. Peedell, Andrew Protheroe, Angus Robinson, Narayanan Srihari, Rajaguru Srinivasan, John Staffurth, Santhanam Sundar, Shaun Tolan, David Tsang, John Wagstaff, Mahesh Parmar
Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial
Christopher Parker, Nicholas D. James, Chris Brawley, Noel W. Clarke, Alex Hoyle, Adnan Ali, A.W.S. Ritchie, Gerhardt Attard, Simon Chowdhury, William Cross, David P. Dearnaley, Silke Gillessen, Clare Gilson, Robert J. Jones, Ruth E. Langley, Zafar Malik, Malcolm D. Mason, David Matheson, Robin Millman, John M. Russell, George N. Thalmann, Claire Amos, Roberto Alonzi, Amit Bahl, Alison Birtle, Omar Din, Hassan Douis, Chinnamani Eswar, Joanna Gale, Melissa Gannon, Sai Jonnada, Sara Khaksar, J.F. Lester, Joe M. O’Sullivan, Omi Parikh, Ian Pedley, Delia Pudney, D.J. Sheehan, Narayanan Srihari, Anna Tran, Mahesh Parmar, Matthew R. Sydes
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines
J. Alfred Witjes, Harman Max Bruins, Albert Carrión, Richard Cathomas, Éva Compérat, Jason A. Efstathiou, Rainer Fietkau, Georgios Gakis, Anja Lorch, Alberto Martini, Laura S. Mertens, Richard P. Meijer, Matthew I. Milowsky, Y. Neuzillet, Valeria Panebianco, John Redlef, Michael Rink, Mathieu Rouanne, George N. Thalmann, Sæbjørn Sæbjørnsen, Erik Veskimäe, Antoine G. van der Heijden
Critical Analysis of Bladder Sparing with Trimodal Therapy in Muscle-invasive Bladder Cancer: A Systematic Review
Guillaume Ploussard, Siamak Daneshmand, Jason A. Efstathiou, Harry W. Herr, Nicholas D. James, Claus Rödel, Shahrokh F. Shariat, William U. Shipley, Cora N. Sternberg, George N. Thalmann, Wassim Kassouf